In this episode, Dr. Norbert Gleicher discusses artificial intelligence (AI) and infertility treatment. He goes into depth regarding the benefits of AI as well as the limitations. He highlights the importance of understanding when and how to use AI appropriately and effectively in medicine.

Our founder, Dr. Norbert Gleicher, reported the first successful transvaginal egg retrieval in human history, helping to shape the future of IVF as we know it today. CHR is known for tackling some of the most challenging fertility cases—especially women over 40 and those with diminished ovarian reserve—by offering highly individualized, evidence-based care when others often turn patients away.

Our team has published more than 450 peer-reviewed research papers advancing reproductive medicine, reflecting our deep commitment not only to patient care but to the science that drives better outcomes. At CHR, you're never just a number. You're part of a community focused on giving you the personalized support, science, and hope you deserve.

Website: www.thechr.com

Facebook: https://www.facebook.com/chrnewyork

Instagram: https://www.instagram.com/chrnewyork/

Linkedin: https://www.linkedin.com/company/centerforhumanreproduction/

Pinterest: https://www.pinterest.com/CenterforHumanReproduction/

TikTok: https://www.tiktok.com/@chrnewyork

In this video, Dr. Norbert Gleicher explains the key differences between PGT-A, PGT-M, and PGD, which are all types of preimplantation genetic testing that is used by many fertility clinics during IVF. Many patients hear these terms throughout their journey, but are not quite sure what they really mean or when each test is actually helpful. Dr. Gleicher breaks down the science of each of these tests and gives his insights into which ones are useful.

This discussion may help clarify common misconceptions, outline the limitations of each approach, and provide important context for patients considering genetic testing as part of their IVF treatment.

Brought to you by the Center for Human Reproduction (CHR) on the Upper East Side of New York City. With over 40 years of experience and a history of innovation, CHR has been at the forefront of fertility care since the beginning.

Our founder, Dr. Norbert Gleicher, reported the first successful transvaginal egg retrieval in human history, helping to shape the future of IVF as we know it today. CHR is known for tackling some of the most challenging fertility cases—especially women over 40 and those with diminished ovarian reserve—by offering highly individualized, evidence-based care when others often turn patients away.

Our team has published more than 450 peer-reviewed research papers advancing reproductive medicine, reflecting our deep commitment not only to patient care but to the science that drives better outcomes. At CHR, you're never just a number. You're part of a community focused on giving you the personalized support, science, and hope you deserve.

Website: www.thechr.com

Facebook: https://www.facebook.com/chrnewyork

Instagram: https://www.instagram.com/chrnewyork/

Linkedin: https://www.linkedin.com/company/centerforhumanreproduction/

Pinterest: https://www.pinterest.com/CenterforHumanReproduction/

TikTok: https://www.tiktok.com/@chrnewyork

As we begin a new year, Dr. Norbert Gleicher shares what truly sets CHR apart and what patients can expect when starting treatment with us.

CHR is known for working with patients who often need more individualized care, including women over 40, patients with diminished ovarian reserve, repeat IVF failures, and complex medical histories. In this video, Dr. Gleicher explains why CHR does not believe in one size fits all fertility treatment and how every patient’s care is built around their specific biology, history, and goals.

You will hear what happens after your initial consultation, how in depth diagnostic workups guide treatment decisions, and why CHR closely monitors patients throughout stimulation to adjust protocols in real time. Dr. Gleicher also discusses CHR’s approach to customized stimulation, timing of retrieval, and individualized embryo transfer decisions, including why some patients benefit from Day 3 transfers while others do not.

This offers a clear look at CHR’s philosophy, our commitment to questioning industry norms, and what patients can expect when choosing a clinic that prioritizes thoughtful, data driven, and deeply personalized care.

Brought to you by the Center for Human Reproduction (CHR) on the Upper East Side of New York City. With over 40 years of experience and a history of innovation, CHR has been at the forefront of fertility care since the beginning.

Our founder, Dr. Norbert Gleicher, reported the first successful transvaginal egg retrieval in human history, helping to shape the future of IVF as we know it today. CHR is known for tackling some of the most challenging fertility cases—especially women over 40 and those with diminished ovarian reserve—by offering highly individualized, evidence-based care when others often turn patients away.

Our team has published more than 450 peer-reviewed research papers advancing reproductive medicine, reflecting our deep commitment not only to patient care but to the science that drives better outcomes. At CHR, you're never just a number. You're part of a community focused on giving you the personalized support, science, and hope you deserve.

Website: www.thechr.com

Facebook: https://www.facebook.com/chrnewyork

Instagram: https://www.instagram.com/chrnewyork/

Linkedin: https://www.linkedin.com/company/centerforhumanreproduction/

Pinterest: https://www.pinterest.com/CenterforHumanReproduction/

TikTok: https://www.tiktok.com/@chrnewyork